TEMPUS

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke TEMPUS wurde als Wortmarke am 17.02.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 20. September 2022

Markenform Wortmarke
Aktenzeichen 1527116
Länder Australien Kanada China Europäische Gemeinschaft Großbritannien Israel Indien Japan Südkorea Mexiko Singapur
Basismarke US Nr. , 22. August 2024
Anmeldedatum 17. Februar 2020
Ablaufdatum 17. Februar 2030

Markeninhaber

600 WEST CHICAGO AVENUE, Suite 510
Chicago IL 60654
US

Markenvertreter

27777 Franklin Rd., Suite 2500 Southfield MI 48034 US

Waren und Dienstleistungen

09 Artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for cardiac diagnostics and electrophysiology; artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for diagnostics and medical, clinical and research testing in the fields of diabetes, neurology, psychiatry, and depression
42 Medical research in the field of cardiology; medical and scientific research related to cardiology and electrophysiology; providing medical and scientific research information in the field of cardiology and electrophysiology; medical and scientific research in the field of cardiology and electrophysiology; research and development services in the field of cardiology and electrophysiology; computer system analysis for use in cardiology and electrophysiology; computer system design for use in cardiology and electrophysiology; software development for cardiac diagnostics and cardiology and electrophysiology; platform as a service (paas) for operating cardiology and electrophysiology clinical decision support; software as a service (saas) for cardiology and electrophysiology clinical decision support; platform as a service (paas) for cardiology and electrophysiology clinical decision support; software as a service (saas) employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for cardiology and electrophysiology; platform as a service (paas) employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for cardiology and electrophysiology; medical research in the fields of diabetes, neurology, and depression diagnostics and testing; medical and scientific research related to diabetes, neurology, and depression diagnostics and testing; providing medical and scientific research information in the fields of diabetes, neurology, and depression diagnostics and testing; medical and scientific research in the fields of diabetes, neurology, and depression diagnostics and testing; research and development services in the fields of diabetes, neurology, and depression diagnostics and testing; computer system analysis for use in diabetes, neurology, and depression diagnostics and testing; computer system design for use in diabetes, neurology, and depression diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of diabetes, neurology, and depression diagnostics and testing; platform as a service (paas) for operating clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; software as a service (saas) for clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; platform as a service (paas) for clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; software as a service (saas) employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms in the fields of diabetes, neurology, and depression diagnostics and testing; platform as a service (paas) employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms in the fields of diabetes, neurology, and depression diagnostics and testing
44 Medical services in the field of cardiology; medical services in the field of electrophysiology; providing medical information in the fields of cardiology and electrophysiology; medical services in the field of diabetes, neurology, and depression diagnostics and testing; providing medical information in the fields of diabetes, neurology, and depression diagnostics and testing
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
03. August 2022 2022/38 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
16. Mai 2022 2022/21 Gaz MX Ablehnung
08. September 2021 2021/37 Gaz CA Ablehnung
09. Juli 2021 2021/28 Gaz KR Ablehnung
27. Mai 2021 2021/22 Gaz JP Ablehnung
01. März 2021 2021/10 Gaz IN RAW: Rule 18ter(2)(i) GP following a provisional refusal
10. Dezember 2020 2020/51 Gaz IL Ablehnung
07. Dezember 2020 2020/50 Gaz US RAW: Division or Merger of Basic Registration
25. November 2020 2020/48 Gaz GB Ablehnung
05. November 2020 2020/45 Gaz SG Ablehnung
03. November 2020 2020/45 Gaz AU Ablehnung
15. September 2020 2020/38 Gaz EM Ablehnung
04. September 2020 2020/38 Gaz CN Ablehnung
20. Juli 2020 2020/33 Gaz IN Ablehnung
04. Mai 2020 2020/20 Gaz US Korrektur
17. Februar 2020 2020/15 Gaz US Eintragung

ID: 141527116